Cargando…
Neuroblastoma cells undergo transcriptomic alterations upon dissemination into the bone marrow and subsequent tumor progression
Neuroblastoma is the most common extracranial solid tumor in childhood. The vast majority of metastatic (M) stage patients present with disseminated tumor cells (DTCs) in the bone marrow (BM) at diagnosis and relapse. Although these cells represent a major obstacle in the treatment of neuroblastoma...
Autores principales: | Rifatbegovic, Fikret, Frech, Christian, Abbasi, M. Reza, Taschner‐Mandl, Sabine, Weiss, Tamara, Schmidt, Wolfgang M., Schmidt, Iris, Ladenstein, Ruth, Ambros, Inge M., Ambros, Peter F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725737/ https://www.ncbi.nlm.nih.gov/pubmed/28921546 http://dx.doi.org/10.1002/ijc.31053 |
Ejemplares similares
-
Bone marrows from neuroblastoma patients: An excellent source for tumor genome analyses
por: Abbasi, M. Reza, et al.
Publicado: (2014) -
Enriched Bone Marrow Derived Disseminated Neuroblastoma Cells Can Be a Reliable Source for Gene Expression Studies—A Validation Study
por: Rifatbegovic, Fikret, et al.
Publicado: (2015) -
Metronomic topotecan impedes tumor growth of MYCN-amplified neuroblastoma cells in vitro and in vivo by therapy induced senescence
por: Taschner-Mandl, Sabine, et al.
Publicado: (2015) -
Landscape of Bone Marrow Metastasis in Human Neuroblastoma Unraveled by Transcriptomics and Deep Multiplex Imaging
por: Lazic, Daria, et al.
Publicado: (2021) -
Schwann cell plasticity regulates neuroblastic tumor cell differentiation via epidermal growth factor-like protein 8
por: Weiss, Tamara, et al.
Publicado: (2021)